The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for ...
A new artificial lens implant for cataract treatment, the FineVision HP, has received approval from the Food and Drug Administration for use in the United States.
RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the ...
A retinal implant invented by a Stanford scientist is restoring limited vision to people with advanced macular degeneration, helping some read and recognize faces again.
A few years back, one of my surgical partners, Michael Greenwood, MD, and I had an idea for a product that would make things easier for our patients and us. That idea was to show patients what we mean ...
On a recent afternoon in Paris, a woman was having her eye colour changed from brown to green. She was lying on the operating ...
Hearing aids restore conversations. Dental work restores smiles. Vision correction restores independence. Many of the ...
I heard Wayne had to give up driving because he is blind from glaucoma, but I saw him at the cafe reading a newspaper. I’m struggling to make sense of that: what is glaucoma?” ...
Oh, not those implants, I am talking about the lens implants after cataract removal. Way, way, too late in the overall scheme ...
Alcon (NYSE:ALC) and RxSight (Nasdaq:RXST) announced that they entered into a non-exclusive intraocular lens (IOL) ...
Artificial corneal endothelial implantation produced significant reductions in corneal thickness and improvements in visual acuity in patients with chronic corneal oedema, includi ...
Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results